Abstract: Occlusion of small side branch (SB) may result in significant adverse clinical events. We aim to characterize the predictors of small SB occlusion and incidence of periprocedural myocardial injury (PMI) in coronary bifurcation intervention.
INTRODUCTION
P ercutaneous coronary intervention (PCI) of coronary bifurcation lesion can be technically challenging and result in high rates of periprocedural myocardial injury (PMI). 1 Side branch (SB) occlusion after main vessel (MV) stenting ( Figure 1 ) in coronary bifurcation intervention is one of the most important factors causing PMI. 2 Occlusion of large SBs may result in significant adverse clinical events 3, 4 ; however, occlusion of small SBs was thought to be well tolerated and indifferent. [5] [6] [7] Although small SB occlusion has already been recognized as a contributing factor toward periprocedural myocardial infarction (MI) and resultant clinical outcomes, 8, 9 the incidence, predictors, and PMI rate of small SBs occlusion in coronary bifurcation intervention have not been fully elucidated.
The incidence of small SB occlusion did not draw enough attention of clinical interventionists. Among patients with bifurcation lesions undergoing PCI, there is a significant rate of small SB compromise, which may lead to PMI. 10 Previous studies have reported that PMI was associated with statistically and clinically significant increase in the subsequent risk of death. 11 Accordingly, this study was designed to characterize the predictors, PMI rate, and clinical outcome of small SB occlusion in coronary bifurcation intervention.
METHODS

Study Population
From January 2012 to July 2012, a cohort of 7007 consecutive patients underwent PCI at Fuwai Hospital in Beijing, China. For the present study, specific inclusion criteria were the following: patients with coronary bifurcation lesions (which was defined as a coronary artery narrowing occurring adjacent to or involving the origin of SB 12 ) undergoing PCI; and the bifurcation lesion that consisted of a SB having baseline reference diameter 2.0 mm that is confirmed by the core laboratory and quantitative coronary angiography (QCA) analysis. Exclusion criterion was SB baseline reference diameter >2.0 mm. Among the 7007 patients with 9421 lesions, 7530 no bifurcation lesions and 942 coronary bifurcation lesions with SB baseline reference diameter >2.0 mm were excluded. Finally, 925 patients with 949 bifurcation lesions that met all the inclusion criteria and had no exclusion criteria were included in this study ( Figure 2) .
The Ethics Committee of the Cardiovascular Institute and Fuwai Hospital approved this study. The study complies with the Declaration of Helsinki.
Procedure and Periprocedural Medications
Coronary angioplasty was performed in the conventional manner and coronary stents or other procedures/devices were used only when required. In all cases, the interventional strategy and instrumentation used were at the discretion of the interventional cardiologists. Decisions regarding the treatment strategy for bifurcation lesions were made by individual operators. The administration of periprocedural antiplatelet and antithrombotic medications was based on the operator's discretion and current guidelines. Administration of 300 mg clopidogrel and 300 mg aspirin as loading doses within the 24 hours before the procedure was mandatory. Lifelong aspirin (100 mg/d) was prescribed to all patients. At least 12 months of clopidogrel (75 mg/d) was recommended to all patients.
Data Collection and QCA
Clinical data were obtained through a review of the medical records. All baseline and procedural cineangiograms were reviewed and analyzed by an independent core laboratory. The synergy between PCI with taxus and cardiac surgery (SYNTAX) score 13 and the residual SYNTAX score 14, 15 from all coronary angiograms were assessed by an independent angiographic core laboratory blinded to clinical outcomes. Procedural characteristics such as SB predilation and the presence of a jailed wire in the SB were also recorded.
The baseline reference diameter of SB was calculated by QCA. QCA is performed by using standard quantitative analyses and definitions. 16 A main principle of our QCA approach was to ensure as little observer interference as possible. Angiograms obtained at baseline were analyzed with the use of a computer-based system dedicated to bifurcation analysis (Qangio XA, version7.3; Medis, Leiden, Netherlands). We obtained quantitative angiographic measurements of the 4 segments of the bifurcation lesion: the proximal MV segment, the distal MV segment, the SB segment, and the bifurcation core segment (Figure 3 ). Bifurcation core was defined as the central part of the bifurcation that begins where the common vessel starts to split into 2 branches and ends at the cardinal point, 17 the area which is calculated by the Qangio XA software.
Blood samples were routinely obtained from patients before and after the procedure. Creatine kinase-myocardial band (CK-MB) activity was determined using an immunoinhibition assay and confirmed by mass spectrometry at the Fuwai Hospital Biochemistry Laboratory.
Follow-up data at 12 months were obtained during an outpatient clinic visit or by phone. Events ascertained at follow-up included all-cause mortality (cardiac or noncardiac), recurrence of the angina pectoris, rehospitalization, MI, any revascularization, and stent thrombosis. Events were defined according to the Academic Research Consortium definitions. 18 Definitions SB occlusion was defined as absence of flow in the SB post-PCI or any thrombolysis in myocardial infarction (TIMI) flow grade decrease in SB.
Recent studies have reported that measurement of CK-MB rather than troponin allows more accurate diagnosis of PMI; thus, we used CK-MB as a biomarker for PMI instead of troponin values. 19, 20 PMI was defined as a postprocedural CK-MB level higher than upper limit of normal (ULN); periprocedural MI was defined as an elevation of CK-MB !3 Â ULN. 18 The ULN for CK-MB at our institution is 24 U/L.
Statistical Methods
Continuous data were presented as mean AE standard deviation and compared using the Student t test. Categorical variables were summarized as counts and percentages and compared by x 2 test or Fisher exact test as appropriate. All P values were 2-tailed, and a P value of <0.05 was considered statistically significant. All analyses were performed with SAS 9.4 system (SAS Institute, Cary, NC). Any variable having a significant univariate association with SB occlusion (P 0.25) was selected as a candidate for the multivariable analysis. The multivariable model was then built by stepwise variable selection with same entry and exit criteria as in the univariable analysis. Thirty variables such as sex, acute MI, history of stroke, and jailed wire in SB were candidates for the multivariable model.
RESULTS
Patient, Lesion, and Procedural Characteristics
SB occlusion occurred in 86 (9.1%) of 949 bifurcation lesions. Of SB occlusion, total occlusion occurred in 64 (74.4%) of lesions and a decrease in TIMI flow occurred in 22 (25.6%) lesions. Blood flow in SB was restored spontaneously in 4 (4.7%) lesions and by SB intervention in 5 (5.8%) lesions of 86 occluded SB; 77 (89.5%) lesions occluded permanently.
Patient characteristics are shown in Table 1 . All the baseline characteristics were not significantly different between the 2 groups. There was no significant difference in SYNTAX score or residual SYNTAX score between the 2 groups. Lesion and procedural characteristics are presented in Table 2 . Among lesion characteristics, location of bifurcation, Medina classification, and distribution of plaque differed significantly between the 2 study groups. Among procedural characteristics, dissection before MV stenting and TIMI flow grade before MV stenting were significantly different between the 2 groups. Quantitative coronary angiographic data are presented in Table 3 . There were significant differences between the 2 groups in reference diameter of all 4 parts. However, regarding the lesion length, only the lesion length of bifurcation core was significantly different between the 2 groups. Diameter ratio between MV and SB in SB occlusion group (1.7 AE 0.3) was significantly higher than no SB occlusion group (1.6 AE 0.3) (P < 0.001).
Predictors of SB Occlusion
After adjustment using a multiple logistic regression model, true bifurcation lesion, irregular plaque, predilation in SB, preprocedural SB TIMI flow grade, preprocedural diameter stenosis of distal MV, preprocedural diameter stenosis of bifurcation core, bifurcation angle, diameter ratio between MV and SB, diameter stenosis of SB before MV stenting, and MV lesion length remained significant and independent risk factors of SB branch occlusion ( Table 4 ). The variance inflation factor (Table 4) showed absence of multicollinearity among these independent predictors.
Incidence of PMI
Periprocedural cardiac enzymes were obtained from 97.74% (821/840) patients in the no SB occlusion group and from 97.65% (83/85) patients in the SB occlusion group. Compared with patients with no SB occlusion, patients in the SB occlusion group have significant higher elevations of postprocedural CK-MB. A significantly higher incidence of postprocedural CK-MB elevation was observed in patients with angiographic evidence of SB occlusion group compared with those in no SB occlusion group in each cutoff level (Figure 4) .
The frequency of PMI was greater in SB occlusion group (26/83, 31.3%) than no SB occlusion group (77/821, 9.4%) (P < 0.001). Periprocedural MI occurred more frequently in patients of SB occlusion group (6/83, 7.2%) than in those without SB occlusion (11/821, 1.3%) (P < 0.001). Among all 17 patients with periprocedural MI, 5 patients had prolonged ischemic symptoms >20 minutes, and 3 patients had both prolonged chest pain and new Q-wave MI (Q-wave MI developed in 2.9% [3/103] of PMI patients).
Clinical Outcomes
The follow-up duration was 12 months and the follow-up rate was 97.7% (904/925). No death, MI, or stent thrombosis occurred in the overall population. The rates of recurrence of the angina pectoris (0% vs 3.8%, P ¼ 0.14), rehospitalization (1.2% vs 2.4%, P ¼ 0.76), and any revascularization (2.4% vs 3.0%, P ¼ 0.76) were similar between patients with and without SB occlusion.
DISCUSSION
The major findings of the present study are as follows: 9.1% of small SB occluded after MV stenting; irregular plaque, preprocedural diameter stenosis of bifurcation core, as well as other 8 factors were independent predictors of SB occlusion; patients with small SB occlusion had significant higher incidence of PMI; and there is no significant difference in clinical outcome during the 12-month follow-up. Previous studies have reported that the incidence of SB occlusion was 8.4% to 19%. [4] [5] [6] In our study, the rate of SB occlusion was 9.1%. This wide range of SB occlusion rate can be attributable to the difference of reference vessel diameter of SB in these studies. Smaller reference vessel diameter was an independent predictor of SB occlusion reported in the previous study. 5 In our study, the mean reference vessel diameter of SB was 1.72 mm, which was smaller than the study of Hahn et al 4 (SB occlusion rate: 8.4%) and larger than the studies by Kralev et al 5 (SB occlusion rate: 12.5%) and Aliabadi et al 6 (SB occlusion rate: 19%). The rate of SB occlusion increases as the reference vessel diameter of SB becomes smaller.
Identifying the predictors of SB occlusion could help interventional cardiologists to avoid abrupt closure of SB. In our study, several independent predictors have been disclosed by multivariable analyses. Among them, irregular plaque and true bifurcation lesion have been reported as independent predictors of SB occlusion. 4 Previous studies have found that irregular plaque was linked to occlusive coronary artery thrombosis at sites of plaque fissure, rupture, or superficial erosion, which are largely involved in the pathogenesis of such acute events. 21 Plaque surface morphology on coronary angiography can be a highly sensitive marker of plaque instability. The instability of irregular plaque may contribute to the SB occlusion. Preprocedural SB TIMI flow grade are index indicating the baseline coronary blood flow. Arteries with lower TIMI flow grade are easier to have SB occlusion. Diameter ratio between MV and SB was also an important predictor, which was concordant with the results of the previous study. 22 Diameter ratio between MV and SB reflects the relative plaque volume of MV. Larger diameter ratio between MV and SB indicates relatively larger plaque burden to SB. Preprocedural diameter stenosis of distal MV, preprocedural diameter stenosis of bifurcation core, diameter stenosis of SB before MV stenting, and MV lesion length were also indexes reflecting the plaque volume and risk of SB occlusion. SB predilation was an effective way to decrease the stenosis of SB ostium and thus decrease the risk of SB occlusion.
The effect of bifurcation angle on the rate of SB occlusion during PCI is controversial. Previous studies have reported that smaller angle in coronary bifurcations predicted higher SB compromise, restenosis, and major adverse cardiac events (MACEs) rates based on small sample size. 22 In addition, Yoshitaka Goto et al 23 reported that bifurcation angle was not associated with SB compromise after MV stenting. On the other hand, Dzavik et al 24 found that bifurcation angle >508 is an independent predictor of MACE after bifurcation crush stenting. In our study, a wide bifurcation angle predicted SB occlusion after MV stenting. Part of the explanation was that bifurcations with smaller bifurcation angle was easier for flow diversion into SB and too large bifurcation angle might increase the pressure drop and flow resistance, 25 thus increasing the SB occlusion risk. Another potential explanation was that increasing bifurcation angle decreased wall shear stress and increases oscillatory shear index significantly around the carina, 26 which might induce plaque proliferation at the bifurcation region. 27, 28 Higher plaque volume in bifurcation core may contribute to the higher SB occlusion risk. Magnitude of postprocedural CK-MB elevation. Comparisons between the patients with SB occlusion (red bars) and those without SB occlusion (blue bars). The incidence of PMI (CK-MB !1 Â ULN) in SB occlusion group was 31.3%, which was significantly higher than the incidence of PMI in no SB occlusion group (9.4%) (P < 0.0001). Also, significantly higher incidence of postprocedural CK-MB elevation was observed in patients with SB occlusion group compared with those without SB occlusion in other cutoff level: CK-MB !2 Â ULN (9.6% vs 2.4%, P ¼ 0.0024), CK-MB !3 Â ULN (7.2% vs 1.3%, P ¼ 0.0027), and CK-MB !5 Â ULN (4.8% vs 1.1%, P ¼ 0.0248). SB ¼ side branch, CK-MB ¼ creatine kinase myocardial band, ULN ¼ upper limit of the normal.
Small SBs occlusion was thought to be well tolerated. [6] [7] [8] In our study, both the rate of PMI and periprocedural MI were significantly higher in SB occlusion group than no SB occlusion group. CK-MB levels were significantly higher after stenting in patients with SB occlusion than in patients without SB occlusion. Previous studies have reported that even a small increase in CK-MB levels after PCI is associated with significantly higher risk of late mortality. 11, [29] [30] [31] However, the present study showed no significant differences in clinical outcome during the 12-month follow-up. The low residual SYNTAX score in both the groups (3.5 AE 5.3 in no SB occlusion group vs 4.2 AE 6.0 in SB occlusion group, P ¼ .29) may explain the low incidence of MACEs. Greater sample sizes and a longer follow-up period are required to fully determine the effect of small SB occlusion on clinical outcome.
Prevention of SB occlusion may be useful for avoiding PMI. Identifying the predictors of small SB occlusion could help to prevent SB occlusion. For small SBs with high occlusion risk, jailed-balloon technique is recommended in consideration of that this technique was associated with lower rates of SB loss and a high procedural success rate. 32, 33 However, the mean reference of SB was 1.7 AE 0.2 mm in the present study and not all SBs were suitable for jailed-balloon technique. Thus, other approaches for preventing PMI were also needed. Previous studies have reported that a single high loading dose of atorvastatin or clopidogrel could reduce the incidence of PMI in elective PCI. 34, 35 Other novel approaches such as intravenous vitamin C infusion, trimetazidine intake before elective PCI, and lower inflation maximal pressure were also considered to be associated with less PMI. [36] [37] [38] Compared with the previous studies, [5] [6] [7] [8] the strength of our study is that the present large-scale study has included all the clinical, angiographic, and procedural factors, as well as other innovative parameters such as diameter ratio between MV and SB, which is significantly predictive of SB occlusion. Another strength of our study is that the study was conducted in a consecutive cohort of bifurcation patients, which could reflect the real-world clinical practice. In addition, not only the baseline but also the procedural angiography is analyzed in the present study, risk factors in procedural cineangiograms such as diameter stenosis of SB before MV stenting were reported to be independent predictors of small SB occlusion for the first time. Last, but not least, the bifurcation core is the area most adjacent to SB and as such a smaller diameter stenosis could be a correlate of plaque shift during MV PCI. The present study performed QCA analysis with the use of a computer-based system dedicated to bifurcation analysis, thus bifurcation core is involved as a novel and important parameter in QCA analysis. Preprocedural diameter stenosis of bifurcation core is found to be an independent risk factor of small SB occlusion. We have brought this vital definition, bifurcation core, to the forefront.
Study Limitation
First, our study is limited by the retrospective single-center design and unknown confounding factors cannot be excluded. Second, selection of treatment strategies, stent types, and other instruments were at the discretion of operators. Our findings are subject to selection bias and compounded with unmeasured variables. Third, this study principally included patients with coronary bifurcation disease that is defined by European Bifurcation Club and excluded patients with bifurcation lesions with SB >2 mm in diameter. The incidence and predictors of SB occlusion would be expected to be different in larger SB. Last, because of the sample size, follow-up period, and low residual SYNTAX score, the incidence of MACE is low and further analysis of clinical outcomes is not available. Greater sample sizes and a longer follow-up period are required in future studies.
CONCLUSION
After MV stenting in coronary bifurcation intervention, 9.1% SB with reference vessel diameter 2 mm occluded. True bifurcation lesion, irregular plaque, predilation in SB, preprocedural SB TIMI flow grade, preprocedural diameter stenosis of distal MV, preprocedural diameter stenosis of bifurcation core, bifurcation angle, diameter ratio between MV and SB, diameter stenosis of SB before MV stenting, and MV lesion length are independent predictors of small SB occlusion. Patients with small SB occlusion had significant higher incidence of PMI.
